LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

AstraZeneca

Status: Not yet enrolling

Conditions: Lung Neoplasms

Study type: Observational

Funder types: Industry

Identifiers

NCT07143110

D133HR00044

Details and patient eligibility

About

LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.

Enrollment: 60,000 estimated patients

Sex: All

Ages: 18 to 130 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with lung cancer between January 1, 2018 and end of the Selection Period.
• Patient is 18 years of age or older on diagnosis date.
• Patient has at least 12 months of health insurance coverage prior to the diagnosis date.

Exclusion criteria

• Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.
• Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.
• Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).
• Non-Ontario or non-Alberta resident on diagnosis date.

Trial design

60,000 participants in 2 patient groups

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)